The Encapsulation Strategies for Targeted Delivery of Probiotics in Preventing and Treating Colorectal Cancer: A Review
Advanced Science · 2025-05 · 12 (18)
DOI: 10.1002/advs.202500304 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 07.04.2025. Verfasst von Hao Zhong und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Food Science and Technology, Zhejiang University of Technology, Hangzhou, 310014, China. Hauptthemen laut MEDLINE: Probiotics, Colorectal Neoplasms, Drug Delivery Systems. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 250 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, "Pioneer" and "Leading Goose" R&D Program of Zhejiang, Key Laboratory of Tropical Fruits and Vegetables Quality and Safety, State Administration for Market Regulation.
Abstract (Originalsprache)
Colorectal cancer (CRC) ranks as the third most prevalent cancer worldwide. It is associated with imbalanced gut microbiota. Probiotics can help restore this balance, potentially reducing the risk of CRC. However, the hostile environment and constant changes in the gastrointestinal tract pose significant challenges to the efficient delivery of probiotics to the colon. Traditional delivery methods are often insufficient due to their low viability and lack of targeting. To address these challenges, researchers are increasingly focusing on innovative encapsulation technologies. One such approach is single‐cell encapsulation, which involves applying nanocoatings to individual probiotic cells. This technique can improve their resistance to the harsh gastrointestinal environment, enhance mucosal adhesion, and facilitate targeted release, thereby increasing the effectiveness of probiotic delivery. This article reviews the latest developments in probiotic encapsulation methods for targeted CRC treatment, emphasizing the potential benefits of emerging single‐cell encapsulation techniques. It also analyzes and compares the advantages and disadvantages of current encapsulation technologies. Furthermore, it elucidates the underlying mechanisms through which probiotics can prevent and treat CRC, evaluates the efficacy and safety of probiotics in CRC treatment and adjuvant therapy, and discusses future directions and potential challenges in the targeted delivery of probiotics for CRC treatment and prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Food Science and Technology, Zhejiang University of Technology, Hangzhou, 310014, China.
- Moganshan Institute ZJUT, Kangqian, Deqing, 313200, China.
- Sanya Branch of Hainan Academy of Inspection and Testing, San Ya, 572011, China.
ORCID-Profile: Hao Zhong
Förderung
- National Natural Science Foundation of China
- "Pioneer" and "Leading Goose" R&D Program of Zhejiang
- Key Laboratory of Tropical Fruits and Vegetables Quality and Safety, State Administration for Market Regulation
- Zhejiang University of Technology- Company Crosswise Project
Zitieren
APA
Zhong, H., Jiang, J., Hussain, M., Zhang, H., Chen, L., & Guan, R. (2025). The Encapsulation Strategies for Targeted Delivery of Probiotics in Preventing and Treating Colorectal Cancer: A Review. Advanced Science, 12(18). https://doi.org/10.1002/advs.202500304
Vancouver
Zhong H, Jiang J, Hussain M, Zhang H, Chen L, Guan R. The Encapsulation Strategies for Targeted Delivery of Probiotics in Preventing and Treating Colorectal Cancer: A Review. Advanced Science. 2025;12(18). doi:10.1002/advs.202500304
BibTeX
@article{Zhong2025,
author = {Zhong, Hao and Jiang, Jin and Hussain, Muhammad and Zhang, Haoxuan and Chen, Ling and Guan, Rongfa},
title = {The Encapsulation Strategies for Targeted Delivery of Probiotics in Preventing and Treating Colorectal Cancer: A Review},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {18},
doi = {10.1002/advs.202500304}
}
EUVIMED